EXT1 and breast neoplasm: Increased EXT1 mRNA expression has been found in estrogen receptor (ER)-negative breast tumors [22], whereas gene expression profiling of human breast tumor samples indicates that diminished expression of EXT1 in early-stage ER positive lymph-node negative breast cancer patients might predict an increased risk for metastasis [23].